AU2002213048A1 - Phosphate transport inhibitors - Google Patents

Phosphate transport inhibitors

Info

Publication number
AU2002213048A1
AU2002213048A1 AU2002213048A AU1304802A AU2002213048A1 AU 2002213048 A1 AU2002213048 A1 AU 2002213048A1 AU 2002213048 A AU2002213048 A AU 2002213048A AU 1304802 A AU1304802 A AU 1304802A AU 2002213048 A1 AU2002213048 A1 AU 2002213048A1
Authority
AU
Australia
Prior art keywords
transport inhibitors
phosphate transport
phosphate
inhibitors
transport
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002213048A
Inventor
Robert G. Franz
Joseph Weinstock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU2002213048A1 publication Critical patent/AU2002213048A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
AU2002213048A 2000-10-05 2001-10-05 Phosphate transport inhibitors Abandoned AU2002213048A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US23806800P 2000-10-05 2000-10-05
US60238068 2000-10-05
US60/238,068 2000-10-05
PCT/US2001/031318 WO2002028353A2 (en) 2000-10-05 2001-10-05 Phosphate transport inhibitors

Publications (1)

Publication Number Publication Date
AU2002213048A1 true AU2002213048A1 (en) 2002-04-15

Family

ID=22896359

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002213048A Abandoned AU2002213048A1 (en) 2000-10-05 2001-10-05 Phosphate transport inhibitors

Country Status (2)

Country Link
AU (1) AU2002213048A1 (en)
WO (1) WO2002028353A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19830431A1 (en) * 1998-07-08 2000-01-13 Hoechst Marion Roussel De Gmbh Sulfonylamino-carboxylic acid N-arylamides as guanylate cyclase activators
SE0001899D0 (en) 2000-05-22 2000-05-22 Pharmacia & Upjohn Ab New compounds
SK288015B6 (en) 2001-06-11 2012-11-05 Virochem Pharma Inc. Thiophene derivatives as antiviral agents for flavivirus infection
GB2378179A (en) * 2001-08-03 2003-02-05 Pantherix Ltd Aromatic sulfonamides and their use in treating bacterial diseases
EP1461333A1 (en) * 2001-11-22 2004-09-29 Biovitrum Ab Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
RS44304A (en) 2001-11-22 2007-06-04 Biovitrum Ab., Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
US7119120B2 (en) * 2001-12-26 2006-10-10 Genzyme Corporation Phosphate transport inhibitors
US7119112B2 (en) * 2002-02-28 2006-10-10 Icagen, Inc. Sulfonamides as potassium channel blockers
PT1569929E (en) 2002-12-10 2010-06-18 Virochem Pharma Inc Compounds and methods for the treatment or prevention of flavivirus infections
US7288538B2 (en) 2003-02-20 2007-10-30 Encysive Pharmaceuticals, Inc. Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists
EP1610753A4 (en) * 2003-02-20 2007-07-04 Encysive Pharmaceuticals Inc Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
NZ563909A (en) 2005-05-13 2011-10-28 Virochem Pharma Inc Thiophene derivatives and their use for the treatment or prevention of flavivirus infections
GB0526255D0 (en) 2005-12-22 2006-02-01 Novartis Ag Organic compounds
EP2058310A4 (en) 2006-09-01 2010-11-17 Kyorin Seiyaku Kk Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor comprising the derivative
US20110028469A1 (en) * 2007-10-05 2011-02-03 Anderson Eric C Thiphene-2-Carboxamide Derivatives As Modulators of CCR9 Receptor
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
KR20200111230A (en) 2008-12-31 2020-09-28 알데릭스, 인코포레이티드 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
EP2426117A4 (en) * 2009-04-30 2012-09-19 Sumitomo Chemical Co Thiophene derivative
MX2012014273A (en) 2010-06-07 2013-03-22 Novomedix Llc Furanyl compounds and the use thereof.
EA023955B1 (en) * 2011-10-27 2016-07-29 Астеллас Фарма Инк. Aminoalkyl-substituted n-thienyl benzamide derivative
WO2014029983A1 (en) 2012-08-21 2014-02-27 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
MX2015014351A (en) 2013-04-12 2016-04-20 Ardelyx Inc Nhe3-binding compounds and methods for inhibiting phosphate transport.
CN110291082A (en) 2017-01-09 2019-09-27 阿德利克斯股份有限公司 The inhibitor for the antiport that NHE is mediated
AU2018205400B2 (en) 2017-01-09 2022-07-14 Ardelyx, Inc. Compounds useful for treating gastrointestinal tract disorders
WO2019167863A1 (en) 2018-02-27 2019-09-06 日本曹達株式会社 Heteroaryl sulfonamide compound and pest control agent
WO2022193187A1 (en) * 2021-03-17 2022-09-22 Biofront Ltd. (Cayman) Modulators of fpr1 and methods of using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03204875A (en) * 1989-10-03 1991-09-06 Wakamoto Pharmaceut Co Ltd Tetrazoleacetic acid derivative and aldose reductase inhibitor comprising same derivative as active ingredient
AU761983B2 (en) * 1998-07-08 2003-06-12 Sanofi-Aventis Deutschland Gmbh Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation,their use and pharmaceutical preparations comprising them

Also Published As

Publication number Publication date
WO2002028353A2 (en) 2002-04-11
WO2002028353A3 (en) 2002-07-11

Similar Documents

Publication Publication Date Title
AU2002213048A1 (en) Phosphate transport inhibitors
AU2001258771A1 (en) -secretase inhibitors
AU2001237041A1 (en) Kinase inhibitors
AU4882101A (en) Mmp-12 inhibitors
AU2001234088A1 (en) TNF-alpha inhibitors
AU2002211663A1 (en) Nf-$g(k)b inhibitors
IL147697A0 (en) Phosphate transport inhibitors
AU2001258784A1 (en) Tyrosine phosphatase inhibitors
AU2001259354A1 (en) Phosphate transport inhibitors
AU2001285750A1 (en) Urokinase inhibitors
AU2001236052A1 (en) Urease inhibitors
AU2001294557A1 (en) Thrombin inhibitors
IL152587A0 (en) Phosphate transport inhibitors
AU2002211662A1 (en) Nf-kappab inhibitors
AU2002222627A1 (en) Tak1 inhibitors
AU2002218760A1 (en) Transport system
AU7961300A (en) Kainic acid neurocytotoxicity inhibitors
AU3235100A (en) Prothease inhibitors
AU2001232245A1 (en) Tnf- alpha inhibitors
AU2002224550A1 (en) Corrosion inhibitors
GB0030284D0 (en) Enzyme inhibitors
AUPP885899A0 (en) Transport aid
AU1588901A (en) Protease inhibitors
AU2030999A (en) Glycine transport inhibitors
AU1474801A (en) Protease inhibitors